Lupin Receives USFDA EIR for its Pithampur Unit-3 Facility
Global pharmaceutical company Lupin Limited announced that it has received the Establishment Inspection Report (EIR) from the U.S. Food and…
Lupin
Read More
India’s Pharma Exports Face High Risk Amid US Tariff
India’s pharmaceutical sector is staring at heightened uncertainty following US President Donald Trump’s recent increased tariff on Indian goods. On…
The rising obesity epidemic in India
Overweight and obesity are becoming more and more common in India, affecting not only adults but also youngsters. The regional…
Lupin’s Pithampur Unit-1 facility has received an EIR from the US FDA, with a classification of VAI
Global pharmaceutical giant Lupin Limited (Lupin) said today that it received the United States Food and Drug Administration’s (U.S. FDA)…
Lupin Acquires Huminsulin from Eli Lilly to Strengthen Diabetes Care Portfolio in India
Global pharmaceutical company Lupin has announced the acquisition of the Huminsulin brand in India from Eli Lilly and Company. This…
2024 IPO Boom: India’s Healthcare and Pharma Sectors Secure ₹14,811 Crore – A Five-Year High In 2024
Credit:- Sugandh Khandelwal India’s healthcare and pharmaceutical sectors raised ₹14,811 crore through initial public offerings (IPOs), marking the highest annual…
Lupin Secures USFDA Nod for Generic HIV Treatment Tablets
Lupin Limited a major global pharmaceutical announced on November 18th that it has received approval from the United States Food…
Scope Ophthalmics and Lupin Join Forces: Unleashing a Breakthrough Transformation in Eyecare Solutions in Mexico!
Scope Ophthalmics and Lupin Partner to Launch Eyecare Products in Mexico Scope Ophthalmics, a leader in ophthalmic products, has announced…
Lupin and Huons Join Forces to Revolutionize Dry Eye Treatment in Mexico, Promising Life-Changing Relief
Lupin and Huons Partner to Introduce Innovative Dry Eye Treatment in Mexico Lupin, came in to a groundbreaking collaboration with…